Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $43.00 by Analysts at Barclays

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its target price reduced by research analysts at Barclays from $76.00 to $43.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an "overweight" rating on the stock. Barclays's price objective would suggest a potential upside of 12.48% from the company's current price.

Several other analysts also recently issued reports on ACHC. Cantor Fitzgerald reiterated a "neutral" rating and set a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st. StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Friday. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a "hold" rating in a report on Friday, August 2nd. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a report on Monday. Finally, KeyCorp initiated coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a "sector weight" rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $79.67.

Acadia Healthcare Stock Down 0.9 %

ACHC stock traded down $0.36 during mid-day trading on Friday, hitting $38.23. The stock had a trading volume of 1,132,291 shares, compared to its average volume of 1,013,094. The stock has a market capitalization of $3.55 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.64 and a beta of 1.33. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $87.77. The company has a fifty day moving average of $54.95 and a 200 day moving average of $64.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 earnings per share. On average, equities analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently modified their holdings of ACHC. Point72 Asset Management L.P. lifted its stake in Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company's stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the period. Wellington Management Group LLP lifted its position in shares of Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company's stock worth $739,250,000 after buying an additional 1,266,384 shares during the period. Millennium Management LLC boosted its stake in Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company's stock valued at $73,640,000 after buying an additional 1,055,894 shares in the last quarter. Holocene Advisors LP grew its position in Acadia Healthcare by 201.5% in the third quarter. Holocene Advisors LP now owns 972,513 shares of the company's stock valued at $61,667,000 after acquiring an additional 649,997 shares during the period. Finally, William Blair Investment Management LLC raised its stake in Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company's stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.